MedTrace Logo

Mind-body Resiliency Intervention for Fear of Cancer Recurrence

NCT04876599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-10-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test the feasibility of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (FOR) among cancer survivors.

Conditions

  • Cancer
  • Coping Skills
  • Coping Behavior

Interventions

BEHAVIORAL

IN FOCUS

Adapted Resiliency Group Intervention

BEHAVIORAL

Usual Care

Referral to Virtual Group Support

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Daniel L Hall, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-09
Primary Completion
2022-08-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04876599 on ClinicalTrials.gov